Year : 2019
In Silico Discovery of Novel Ligands for Anti-Tubercular Targets Using Computed Aided Drug Design
Cite this Research Publication : V. Bhaskar, Namboori, K., and Dr. Leena K. Pappachen, “In Silico Discovery of Novel Ligands for Anti-Tubercular Targets Using Computed Aided Drug Design”, Research Journal of Pharmacy and Technology, vol. 12, no. 11, pp. 5646-5650, 2019.
Year : 2019
Glutathione Derivative as Potential Drugs for Colorectal Cancer Resulted by APC Mutations
Cite this Research Publication : S. James, P. K. Krishnan Namboori, and Dr. Leena K. Pappachen, “Glutathione Derivative as Potential Drugs for Colorectal Cancer Resulted by APC Mutations”, Research Journal of Pharmacy and Technology, vol. 12, no. 8, 2019.
Publisher : Research Journal of Pharmacy and Technology
Year : 2017
Evaluation of colorectal cancer (CRC) epidemiology a pharmacogenomic approach
Cite this Research Publication : A. Ma HimaVyshnavi, Anand, C. Lb, Deepak, O. Mc, and P. K. Krishnan Namboori, “Evaluation of colorectal cancer (CRC) epidemiology a pharmacogenomic approach”, Journal of Young Pharmacists, vol. 9, pp. 36-39, 2017.
Publisher : Journal of Young Pharmacists
Year : 2017
Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.
Cite this Research Publication :
P. M. Iyer, Karthikeyan, S., P Kumar, S., and Namboori, P. K. Krishnan, “Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.”, Funct Integr Genomics, vol. 17, no. 4, pp. 375-385, 2017.
Publisher : Funct Integr Genomics
Year : 2017
Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease—a pharmacogenomic approach
Cite this Research Publication : P. M. Iyer, Karthikeyan, S., P. Kumar, S., and P. K. Krishnan Namboori, “Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease—a pharmacogenomic approach”, Functional and Integrative Genomics, pp. 1-11, 2017
Publisher : Functional and Integrative Genomics
Year : 2016
Retrometabolic approach for designing personalized anti- cancer drug molecules for controlling breast cancer resulted by BRCA1 mutations
Cite this Research Publication : P. M. Iyer, P. Kumar, S., Shanmugam, K., and P. K. Krishnan Namboori, “Retrometabolic approach for designing personalized anti- cancer drug molecules for controlling breast cancer resulted by BRCA1 mutations”, Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), vol. 14, no. 1, pp. 56 - 64, 2016
Publisher : Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics) .
Year : 2016
Prediction of epigenetic variations in alzheimer’s disease identification of ethnic variants through pharmacogenomic approach
Cite this Research Publication : PaSanjay Kumar, Karthikeyan, Sa, Iyer, P. Mb, and P. K. Krishnan Namboori, “Prediction of epigenetic variations in alzheimer's disease identification of ethnic variants through pharmacogenomic approach”, Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 7, pp. 2742-2745, 2016
Publisher : Research Journal of Pharmaceutical, Biological and Chemical Sciences.
Year : 2016
Brca1 responsiveness towards breast cancer-a population-wise pharmacogenomic analysis
Cite this Research Publication : P. Mab Iyer, Kumar, PbSanjay, Karthikeyan, Sb, and P. K. Krishnan Namboori, “Brca1 responsiveness towards breast cancer-a population-wise pharmacogenomic analysis”, International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, pp. 267-270, 2016
Publisher : International Journal of Pharmacy and Pharmaceutical Sciences.
Year : 2015
Perusal of Mbl2 gene -Susceptibility to tuberculosis in different Indian populations
Cite this Research Publication : C. V. Umesh, Jamsheer, A. M., Alex, P. M., and P. K. Krishnan Namboori, “Perusal of Mbl2 gene -Susceptibility to tuberculosis in different Indian populations”, Journal of Applied Pharmaceutical Science, vol. 5, no. 9, pp. 097-099, 2015.
Publisher : Journal of Applied Pharmaceutical Science, Open Science Publishers LLP Inc
Year : 2015
Insilico modeling of chitosan as a drug delivery system
Cite this Research Publication : Ann Elizabeth Silviya, Kavitha G., Narayanankutty Karuppath, and P. K. Krishnan Namboori, “Insilico modeling of chitosan as a drug delivery system”, International Journal of Drug Delivery, vol. 7, no. 1, pp. 27-31, 2015
Publisher : International Journal of Drug Delivery, Advanced Research Journals
Year : 2015
Efficiency of Chitosan Drug Delivery System-A Computational Analysis
Cite this Research Publication : Ann Elizabeth Silviya, Kavitha G., Narayanankutty Karuppath, and P. K. Krishnan Namboori, “Efficiency of Chitosan Drug Delivery System-A Computational Analysis”, International Journal of Current Research, vol. 7, no. 6, 2015.
Publisher : International Journal of Current Research
Year : 2013
Pharmacogenomic analysis of individual variation in prostate cancer
Cite this Research Publication : Sukumaran, Ja, ,, ,, and P. K. Krishnan Namboori, “Pharmacogenomic analysis of individual variation in prostate cancer”, International Journal of Research in Pharmaceutical Sciences, vol. 4, pp. 70-72, 2013
Publisher : International Journal of Research in Pharmaceutical Sciences
Year : 2012
De Novo designing of HDAC inhibitors in cancer therapy
Cite this Research Publication : C. P. Anju, Anusooya, N. J., Deeasree, M., Deepak, O. M., and P. K. Krishnan Namboori, “De Novo designing of HDAC inhibitors in cancer therapy”, International Journal of Pharmaceutical Science and Health Care, vol. 2, pp. 59–66, 2012
Publisher : International Journal of Pharmaceutical Science and Health Care
Year : 2011
PRE-TRANSCRIPTIONAL GENE SILENCING TECHNIQUE FOR CONTROLLING SKIN CANCER
Cite this Research Publication : A. Noushadali, Parimalam, B., R Devi, R., Shilpa, S., A Kumar, S., and P. K. Krishnan Namboori, “PRE-TRANSCRIPTIONAL GENE SILENCING TECHNIQUE FOR CONTROLLING SKIN CANCER”, International Journal of Pharmaceutical Science and Research, vol. 2, no. 5, pp. 1293-1297, 2011
Publisher : International Journal of Pharmaceutical Science and Research
Year : 2011
Insilico modeling and simulation of magnetic nanoparticles for the biological cell isolation technique
Cite this Research Publication : K. V. Gopal, Premkumar, P., Gopakumar, D., P. K. Krishnan Namboori, and Sabarish Narayanan B., “Insilico modeling and simulation of magnetic nanoparticles for the biological cell isolation technique”, International Journal of Nanoscience, vol. 10, no. 1-2, pp. 323-327, 2011.
Publisher : International Journal of Nanoscience
Year : 2011
Electrical conductivity and thermodynamic stability of single walled carbon nanotube using first principles
Cite this Research Publication : A. Ranganath, Ashish, G., K Gopal, V., Narayanankutty Karuppath, Gopakumar, D., and P. K. Krishnan Namboori, “Electrical conductivity and thermodynamic stability of single walled carbon nanotube using first principles”, NanoTrends (Nano Science and Technology Consortium), vol. 11, pp. 18-21, 2011
Publisher : NanoTrends
Year : 2011
Determination of Protein Subcellular Locations using Support Vector Machines
Cite this Research Publication :
M. G. Nirmal, K Gopal, V., and Namboori, P. K., “Determination of Protein Subcellular Locations using Support Vector Machines”, Journal of Computational Intelligence in Bioinformatics, vol. 4, pp. 29-35, 2011.
Publisher : Journal of Computational Intelligence in Bioinformatics
Year : 2011
Computational modeling and simulation of nanomolecular switch for Alzheimer’s disease (A gene silencing technique)
Cite this Research Publication : K. U. Radhagayathri, Mohandas, V. P., Subeesh, T., Dr. Deepa Gopakumar O. S., P. K. Krishnan Namboori, and Ramachandran, K. I., “Computational modeling and simulation of nanomolecular switch for Alzheimer's disease (A gene silencing technique)”, International Journal of Nanoscience, vol. 10, pp. 319-322, 2011
Publisher : International Journal of Nanoscience
Year : 2010
Insilico Analysis of Pac-1 as an Enhancer for Caspase-3 to Promote Apoptosis in Cancer
Cite this Research Publication : M. S. Kumar, Purushothaman, D., K Gopal, V., Premkumar, P., Gopakumar, D., and P. K. Krishnan Namboori, “Insilico Analysis of PAC-1 as an Enhancer for Caspase-3 to Promote Apoptosis”, International Journal of Biotechnology and Biochemistry, vol. 6, pp. 595–600, 2010
Publisher : National Conference on Recent Trends in Communication, Computation and Signal Processing
Year : 2010
Insilico Analysis of PAC-1 as an Enhancer for Caspase-3 to Promote Apoptosis
Cite this Research Publication : M. S. Kumar, Purushothaman, D., K Gopal, V., Premkumar, P., Gopakumar, D., and P. K. Krishnan Namboori, “Insilico Analysis of PAC-1 as an Enhancer for Caspase-3 to Promote Apoptosis”, International Journal of Biotechnology and Biochemistry, vol. 6, pp. 595–600, 2010.
Publisher : International Journal of Biotechnology and Biochemistry
Year : 2010
Effect of Non-Coding RNA on Post-Transcriptional Gene Silencing of Alzheimer Disease
Cite this Research Publication :
D. Gopakumar, Mohan, A., Radhagayathri, K. U., Gopal, V., Vasavi, C. S., Premkumar, P., P. K. Krishnan Namboori, and Ramachandran, K. I., “Effect of Non-Coding RNA on Post-Transcriptional Gene Silencing of Alzheimer Disease”, Nature Precedings, 2010.
Publisher : Nature Precedings
Year : 2010
Designing a Drug Additive Against Antibiotic Resistant Gram- positive Bacteria
Cite this Research Publication :
V. Aghila, Lainu, K. L., Mohan, A., Radhagayathri, K. U., K Gopal, V., Krishnan, N. P. K., and Gopakumar, D., “Designing a Drug Additive Against Antibiotic Resistant Gram- positive Bacteria”, International Journal of Biotechnology and Bioengineering Research, vol. 1, pp. 53–61, 2010.
Publisher : International Journal of Biotechnology and Bioengineering Research